LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 82 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q3 2018. The put-call ratio across all filers is 0.18 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $3,086,000 | -86.3% | 480,000 | -79.9% | 0.11% | -85.1% |
| Q4 2018 | $22,513,000 | -56.8% | 2,387,336 | -7.8% | 0.76% | -23.9% |
| Q3 2018 | $52,141,000 | -30.8% | 2,590,212 | +0.3% | 1.00% | -23.8% |
| Q2 2018 | $75,351,000 | +337.7% | 2,583,170 | +346.8% | 1.32% | +282.8% |
| Q1 2018 | $17,217,000 | – | 578,145 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 240,000 | $1,018,000 | 94.79% |
| TANG CAPITAL MANAGEMENT LLC | 9,405,490 | $39,879,000 | 11.22% |
| RTW INVESTMENTS, LP | 2,327,903 | $9,870,000 | 0.15% |
| Boxer Capital, LLC | 890,700 | $3,777,000 | 0.13% |
| FIRST MIDWEST BANK TRUST DIVISION | 89,341 | $379,000 | 0.05% |
| WealthTrust Axiom LLC | 30,400 | $128,000 | 0.04% |
| PREMIER ASSET MANAGEMENT LLC | 51,305 | $217,000 | 0.04% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 18,113 | $77,000 | 0.02% |
| HOLLENCREST CAPITAL MANAGEMENT | 39,000 | $165,000 | 0.02% |
| Inscription Capital, LLC | 10,000 | $42,000 | 0.01% |